|Bid||53.86 x 1000|
|Ask||54.90 x 1400|
|Day's Range||54.02 - 54.96|
|52 Week Range||49.54 - 61.08|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||3.17 (5.63%)|
|Ex-Dividend Date||Aug 13, 2020|
|1y Target Est||N/A|
BD (BDX) receives 2 billion pandemic orders for needles and syringes to support global COVID-19 vaccination efforts.
BD's (BDX) authorization as a CNA is expected to allow it to provide customers with timely information about vulnerabilities in BD products available globally.
BD's (BDX) UCA leverages AI to revolutionize the way microbiology labs conduct urine culture analysis.